Barbara Albientz, Chief Commercialization Officer, Helvion Pharmaceuticals, joins PharmaShots’ Managing Editor Himanshu Sehgal for a riveting dialogue exchange. Barbara shares her experience from the recently held Reuters Events Pharma 2025, where she joined as an affirmative team member for the debate Reality Check: Is Omnichannel Actually Working?
Barbara believes AI will be crucial in segmenting audiences and stakeholders for enhancing tailored interactions and enabling real-time personalized patient experience.
Image Source: Canva
About the Author:
Barbara Albientz
Barbara is an accomplished leader with robust experience in the pharmaceutical and biotechnology industries, specializing in strategic leadership across research, development, and commercialization.
Related Post: Reuters Pharma 2025: Post Conference Talks Featuring Jayasree K. Iyer
